- Home
- XENE vs RXO Comparison
XENE vs RXO Comparison
Compare XENE & RXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XENE | RXO |
|---|---|---|
| Founded | 1996 | 2022 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | 2014 | 2022 |
Fundamental Metrics
Financial Performance| Metric | XENE | RXO |
|---|---|---|
| Price | $37.53 | $27.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 18 |
| Target Price | ★ $71.94 | $27.96 |
| AVG Volume (30 Days) | 1.4M | ★ 4.7M |
| Earning Date | 11-10-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.81 |
| EPS | N/A | ★ N/A |
| Revenue | $311,000.00 | ★ $5,742,000,000.00 |
| Revenue This Year | N/A | $21.81 |
| Revenue Next Year | $2,045.70 | $8.62 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.20 |
| 52 Week Low | $33.38 | $10.43 |
| 52 Week High | $72.66 | $29.90 |
Technical Indicators
Market Signals| Indicator | XENE | RXO |
|---|---|---|
| Relative Strength Index (RSI) | 44.25 | 55.24 |
| Support Level | $33.38 | $25.88 |
| Resistance Level | $39.92 | $29.71 |
| Average True Range (ATR) | 1.21 | 0.60 |
| MACD | 1.00 | -0.39 |
| Stochastic Oscillator | 85.34 | 3.55 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.